Последнее обновление :
19/11/2024
Противовоспалительное средство   Hydrocortisone  
Раствор для перорального приёма
 Бумажный пакет
Стабильность фармацевтических препаратов Стабильность смесей Факторы, которые влияют на стабильность Совместимость Библиография pdf
   Химическая структура  

Раствор для перорального приёма
Библиография   Раствор для перорального приёма   Библиография : Hydrocortisone  
тип публикация
909 Журнал Chong G, Decarie D, Ensom M.H.H.
Stability of hydrocortisone in extemporaneously compounded suspensions.
J Informed Pharmacother 2003 ; 13: 100-110.
2538 Журнал Fawcett JP, Boulton DW, Jiang R, Woods DJ.
Stability of hydrocortisone oral suspensions prepared from tablets and powder.
Ann Pharmacotherapy 1995 ;29:987-990.
2835 Журнал Das Gupta V.
Chemical Stability of Hydrocortisone in an Oral Liquid Dosage Form without Suspending Agents
Int J Pharm Compound 2007 ; 11, 3: 259-261.
3755 Журнал Bourget P, Amin A, Vidal F, Pieyre M, Dosso E.O, Beauvais R, Loeuillet R.
Physicochemical and Microbiological Stabilities of Hydrocortisone in InOrpha Suspending Agent Studied Under Various Condition.
Int J Pharm Compound 2014 ; 18, 5: 427-431.
3810 Журнал Geiger C M, Sorenson B, Whaley P.
Stability Assessment of 10 Active Pharmaceutical Ingredients Compounded in SyrSpend SF.
Int J Pharm Compound 2015 ; 19, 5 : 420-427.
3811 Журнал Nahata Milap C.
Stability of Levothyroxine, Doxycycline, Hydrocortisone, and Pravastatin in Liquid Dosage Forms Stored at Two Temperatures.
Int J Pharm Compound 2015 ; 19, 5 : 428-431.
4063 Журнал Manchanda A, Laracy M, Savji T, Bogner R.
Stability of an Alcohol-free, Dye-free Hydrocortisone (2mg/mL) Compounded Oral Suspension.
Int J Pharm Compound 2018 ;22,1:66-75
4198 Журнал Uriel M, Gomez-Rincon C, Marro D.
Stability of regularly prescribed oral liquids formulated with SyrSpend® SF.
Pharmazie 2018 73;196-201
4530 Журнал Pramar Y, Mandal T, Bostanian L, Kader C, Morris T, Graves R.
Physicochemical and Microbiological Stability of Extemporaneously Compounded Hydrocortisone Oral Suspensions in PCCA Base, SuspendIt.
Int J Pharm Compound 2021 ;25,5:431-439

  Mentions Légales